Raveena Shree R

Raveena Shree R

Auto-generated profile, based on publicly available information

Raveena Shree R

Department of Pharmacology, Karnataka College of Pharmacy, Bangalore, India

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2024 in Biosciences Biotechnology Research Asia
Verified
Journal Article
Open access
DJDeepak Kumar Jha
Deepak Kumar Jha
AHAmani Abdalbagi Eshag Hassan
Amani Abdalbagi Eshag Hassan
RRRaveena Shree R
Raveena Shree R
Skin cancer is a most common disease classified into "melanomas,” which predominantly generates from melanocytes (the cells responsible for producing melanin), and "non-melanomas,” which is comprised of “basal cell carcinoma," which arises from the basal cell located in the deepest layer of the epidermis, and “squamous cell carcinoma,” which originates from the squamous cell found within the epidermal layer. It is influenced by both non-biological (UV rays and environmental exposure) and biological factors, such as genetics and types of skin. For better treatment, initial detection of cancer plays a vital role. Prevention and management of skin cancer requires changes in lifestyle, routine screenings, and modern medical treatments. Some of which are our hope include advancements in imaging techniques, immunotherapy, genetic markers, and plant-based management. As skin cancer cases are increasing worldwide, it is essential to explore various treatment and prevention strategies. Prevention and treatment of skin cancer and patient outcomes could improve by developing medical devices and novel therapeutic approaches. Initial detection, routine screening, and a blend of conventional and innovative treatments are crucial for fighting this widespread disease.